diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who insulin tolerance test is determined to be necessary for pituitary function assessment
Exclusion criteria
Exclusion criteria: 65 years of age or older patients, Patients with a history of ischemic heart disease and seizures Patients who has oral anti-platelet drug or anticoagulant drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AUC10, area under curve until 10 min for PL chip on T-TAS(Total Thrombus-formation Analysis System) and plasma catecholamines at 0min,15min,30min,60min, 90min, 120min before and after insulin load | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)plasma PAI-1(plasminogen activator inhibitor-1) 2) P-selectin and PAC-1 by flowcytometry | — |
Countries
Japan
Contacts
Kagoshima University Graduate School of Medical and Dental Sciences Department of Diabetes and Endocrinology